Allogene Therapeutics, Inc. (ALLO)
NASDAQ: ALLO · Real-Time Price · USD
1.230
+0.020 (1.65%)
At close: Oct 27, 2026, 4:00 PM EDT
1.250
+0.020 (1.63%)
After-hours: Oct 27, 2026, 6:02 PM EDT
Allogene Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $14 | Buy | Maintains | $14 | +1,038.21% | Sep 30, 2026 |
| J.P. Morgan | J.P. Morgan | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Aug 17, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Aug 13, 2026 |
Unknown Analyst UBS No rating | UBS | Buy Reiterates $8 | Buy | Reiterates | $8 | +550.41% | Aug 13, 2026 |
| RBC Capital | RBC Capital | Buy Reiterates $9 | Buy | Reiterates | $9 | +631.71% | Aug 13, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $10 | Buy | Maintains | $10 | +713.01% | Aug 13, 2026 |
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Aug 13, 2026 |
| Oppenheimer | Oppenheimer | Buy Reiterates $7 | Buy | Reiterates | $7 | +469.11% | May 14, 2026 |